Glycon MR

Glycon MR

gliclazide

Manufacturer:

Siam Bheasach

Distributor:

Siam Pharmaceutical

Marketer:

Siam Pharmaceutical
Concise Prescribing Info
Contents
Gliclazide
Indications/Uses
Adults w/ type 2 NIDDM when dietary measures, physical exercise & wt loss alone are insufficient to control blood glucose.
Dosage/Direction for Use
Adult Initially 30 mg daily. Titration: Adjust dose in increments of 30 mg at least 1-mth interval & may be increased after 2 wk in patients who have not responded. Max: 120 mg once daily.
Administration
Should be taken with food: Take w/ breakfast. Tab may be divided into equal doses, do not crush/chew.
Contraindications
Known hypersensitivity to gliclazide or other sulfonylurea or sulfonamides. Type 1 DM; diabetic ketoacidosis (w/ or w/o coma); severe infection & accident. Severe renal or hepatic insufficiency. Treatment w/ miconazole. Lactation.
Special Precautions
Discontinue use if skin rash, blisters, detachment of skin & epithelial lining in oral cavity, throat, nose, genital organ & conjunctivitis occurs. Hypoglycemic symptoms eg, hunger, palpitation, sweating. Malnourished patients. Patients w/ G6PD deficiency. May elevate liver enzymes. Avoid alcohol intake during treatment. Renal impairment. Hepatic function, adrenal &/or pituitary insufficiency. Avoid during pregnancy & lactation. Elderly or debilitated patients.
Adverse Reactions
Hypoglycemia. Angina pectoris, HTN, peripheral edema; depression, dizziness, headache, insomnia, neuralgia; dermatitis, dermatological disease, pruritus, rash, (includes maculopapular & morbilliform rash); hyperglycemia, hyperlipidemia, increased lactate dehydrogenase, lipid metabolism disorder; abdominal pain, constipation, diarrhea, gastritis, gastroenteritis, nausea; UTI; viral infection; arthralgia, arthritis, arthropathy, back pain, myalgia, tendonitis, weakness; conjunctivitis; otitis media; increased serum creatinine; bronchitis, cough, pharyngitis, pneumonia, rhinitis, sinusitis, URTI. DRESS, SJS, TEN.
Drug Interactions
Prolonged hypoglycemia & disulfiram-like reactions w/ ethanol. Increased risk of phototoxic skin reactions w/ aminolevulinic acid. Inhibited metabolism w/ chloramphenicol. Enhanced hypoglycaemic effects w/ sulfonamides. Rarely, concomitant use w/ fluoroquinolones (ie, ciprofloxacin, levofloxacin, gatifloxacin). Increased effects w/ azole antifungals (ie, fluconazole, miconazole, ketoconazole, voriconazole) & cimetidine. Reduced glucose-lowering effects w/ rifampin.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BB09 - gliclazide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Presentation/Packing
Form
Glycon MR tab 60 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in